Free Trial

Ambu A/S Q4 2023 Earnings Report

Ambu A/S logo
$14.18 0.00 (0.00%)
(As of 12/20/2024 ET)

Ambu A/S Earnings Headlines

Ambu A/S goes ex dividend tomorrow
Ambu A/S (AMBBY)
Wall Street Icon: “You must get on the right side of this thing”
I created one of the first quantitative analysis-based stock picking systems long before "quants" became a thing on Wall Street… leading Forbes to call me "King of the Quants." I'm writing to you today because my system has recently uncovered a market phenomenon I haven't seen in 30 years.
Ambu A/S Reports Strong Growth and Strategic Advancements
Ambu A/S (AMBFF) Q4 2024 Earnings Call Transcript
See More Ambu A/S Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Ambu A/S? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Ambu A/S and other key companies, straight to your email.

About Ambu A/S

Ambu A/S (OTCMKTS:AMBBY) develops, produces, and sells medical devices to hospitals, clinics, and rescue services worldwide. The company offers anaesthesia, and patient monitoring and diagnostics products. The company also offers endoscopy products, such as bronchoscopes, rhinolaryngoscopes, duodenoscopes, cystoscopes, and display units; and neurology products, including EEG and EMG electrodes, EMG guided injections, and intraoperative monitoring products. It also provides cardiology products consisting of airway management and anaesthesia products, such as bronchoscopes, video laryngoscopes, double and single lumen tubes, endobronchial blockers, laryngeal and face masks, breathing bags, and resuscitators. In addition, the company offers extrication collars, CPR breathing barriers, video laryngoscopes, and training manikins. The company was founded in 1937 and is headquartered in Ballerup, Denmark.

View Ambu A/S Profile

More Earnings Resources from MarketBeat

Upcoming Earnings